AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lobg M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Lobg M 50mg/500mg Tablet

DiaBeta Duo 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events such as stroke or heart attack. DiaBeta Duo may be prescribed independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose readings, and other medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; cessation should only occur under your physician's guidance. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management, as lifestyle factors significantly influence blood sugar control. Commonly reported side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia, a potential adverse effect when used concurrently with insulin or sulfonylureas, necessitates familiarity with its symptoms and management. This medication isn't universally suitable. Prior to initiating treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women require medical consultation before use. Interaction with other medications is possible; therefore, disclose all current medications to ensure safety. Alcohol should be minimized due to its potential to reduce blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.

Primary Ingredients of Lobg M 50mg/500mg Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of Lobg M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Lobg M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Lobg M 50mg/500mg Tablet with a meal.

Common Side effects of Lobg M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Lobg M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Lobg M 50mg/500mg Tablet with a meal.

How Lobg M 50mg/500mg Tablet works:

Lobg M 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Lobg M 50mg/500mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Lobg M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before recommending its use. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Lobg M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Lobg M 50mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Lobg M 50mg/500mg Tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Lobg M 50mg/500mg tablets in individuals with hepatic impairment is potentially hazardous and should be avoided. Medical advice is recommended.

What if you forget to take Lobg M 50mg/500mg Tablet :

Should you forget a Lobg M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lobg M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Lobg M 50mg/500mg Tablet

Lobg M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Prolonged use of Lobg M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Lobg M 50mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Lobg M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Lobg M 50mg/500mg tablets is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Metformin (like in Lobg M 50mg/500mg Tablet) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Lobg M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Lobg M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Lobg M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Lobg M 50mg/500mg tablets is unsafe and may heighten the risk of lactic acidosis.
Metformin (like in Lobg M 50mg/500mg Tablet) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur while taking Sitagliptin + Metformin, discontinue use and seek immediate medical attention.
Prolonged use of Lobg M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lobg M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Lobg M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Lobg M 50mg/500mg Tablets are contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Lobg M 50mg/500mg tablets is unsafe due to an increased risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Lobg M 50mg/500mg Tablets. This condition, caused by excessive blood lactic acid, is rare but more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Lobg M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lobg M 50mg/500mg Tablet
174